{"gene":"SEPSECS","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":2006,"finding":"SEPSECS (then annotated as SLA/LP) catalyzes the tRNA-dependent conversion of O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) in eukaryotes and archaea. Purified recombinant SepSecS converts Sep-tRNA(Sec) into Sec-tRNA(Sec) in vitro in the presence of sodium selenite and selenophosphate synthetase. Human and archaeal SepSecS genes complement an E. coli SelA deletion strain in vivo, establishing SepSecS as the eukaryotic/archaeal Sec synthase.","method":"In vitro enzyme assay with purified recombinant protein; in vivo complementation of E. coli SelA deletion strain","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution plus in vivo complementation, replicated by independent groups","pmids":["17142313"],"is_preprint":false},{"year":2007,"finding":"SEPSECS (SecS/soluble liver antigen) requires O-phosphoseryl-tRNA([Ser]Sec) as its obligatory substrate (not free phosphoserine or seryl-tRNA), and requires selenophosphate as the selenium donor, to generate selenocysteyl-tRNA([Ser]Sec). This establishes the two-component substrate requirement for SecS activity.","method":"In vitro biochemical reconstitution with purified components (tRNA, PSTK, SEPSECS, selenophosphate synthetase); substrate specificity assays","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1 — full reconstitution of the Sec biosynthesis pathway with defined purified components, replicated across studies","pmids":["17194211"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of human SepSecS (SLA/LP) in complex with tRNA(Sec), phosphoserine, and thiophosphate reveals: (1) SepSecS functions as a tetramer; (2) two tRNA(Sec) molecules bind per tetramer through their 13-bp acceptor-TΨC arm, which has a fold distinct from canonical tRNAs; (3) tRNA binding induces a conformational change in the active site that correctly orients phosphoserine covalently attached to tRNA(Sec) but not free phosphoserine; (4) the reaction proceeds via a pyridoxal phosphate-dependent mechanism.","method":"X-ray crystallography; in vivo and in vitro enzyme assays; active-site analysis","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — atomic-resolution crystal structure combined with in vivo and in vitro functional assays in a single rigorous study","pmids":["19608919"],"is_preprint":false},{"year":2005,"finding":"SLA (SEPSECS) forms a multiprotein complex with SECp43 and tRNA([Ser]Sec) in cells. Knockdown of SECp43 reduces tRNA(Sec) wobble-position methylation (Um34) and decreases selenoprotein expression; double knockdown of SECp43 and SLA further reduces selenoprotein expression. SECp43 and SLA each affect the other's binding to tRNA(Sec). SLA is located primarily in the cytoplasm, but co-transfection with SECp43 causes nuclear translocation of SLA, indicating SECp43 promotes nucleocytoplasmic shuttling of SLA.","method":"RNA interference knockdown; co-immunoprecipitation; subcellular fractionation/localization; selenoprotein expression assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction and localization validated by multiple orthogonal methods (RNAi, co-IP, fractionation) with defined functional readouts","pmids":["16230358"],"is_preprint":false},{"year":2010,"finding":"Loss-of-function mutations in SEPSECS cause autosomal-recessive progressive cerebellocerebral atrophy (PCCA) in humans. Both founder mutations (in Iraqi and Moroccan Jewish populations) disrupt the sole route to selenocysteine biosynthesis and thus abolish selenoprotein synthesis, establishing SEPSECS as an essential enzyme in vivo for selenoprotein generation and brain function.","method":"Human genetics (homozygosity mapping, sequencing); functional inference from established SEPSECS enzymatic role","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — human loss-of-function variants with defined molecular mechanism (abolished Sec synthesis) and clinical phenotype, corroborated by known biochemistry","pmids":["20920667"],"is_preprint":false},{"year":2015,"finding":"Compound heterozygous SEPSECS mutations (p.Thr325Ser and p.Tyr429*) do not completely abolish enzyme activity but lead to decreased selenoprotein levels and increased oxidative protein damage in patient brain tissue, extending the phenotypic spectrum of SEPSECS deficiency to a progressive encephalopathy with elevated lactate. A bacterial activity assay confirmed that the missense mutation partially impairs but does not eliminate SEPSECS function.","method":"Whole-exome sequencing; bacterial complementation activity assay; mass spectrometry; Western blotting; protein oxidation detection","journal":"Neurology","confidence":"High","confidence_rationale":"Tier 1-2 — bacterial activity assay plus multiple biochemical assays on patient tissue; mechanistic link between hypomorphic mutations and partial loss of selenoprotein synthesis established","pmids":["26115735"],"is_preprint":false},{"year":2017,"finding":"SEPSECS, SECp43, SEPHS1, and SEPHS2 form oligomers in eukaryotic cells. SEPHS2 interacts with SEPSECS and SEPHS1; these interactions were confirmed by bioluminescence resonance energy transfer (BRET) assay and co-immunoprecipitation in mammalian cells.","method":"Bioluminescence resonance energy transfer (BRET) assay in mammalian cells; co-immunoprecipitation","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — two orthogonal methods (BRET and co-IP) from a single lab; interaction network defined but downstream functional consequences not fully resolved","pmids":["28414460"],"is_preprint":false},{"year":2000,"finding":"The target antigen of SLA/LP autoantibodies in autoimmune hepatitis is a 422-amino-acid protein (SEPSECS/tRNP(Ser)Sec-associated protein). The protein was identified by cDNA expression library immunoscreening; antibodies eluted from the recombinant protein immunoprecipitate tRNA(Ser)Sec from HeLa cell extracts, demonstrating that the autoantigen is the protein component of the tRNA(Ser)Sec ribonucleoprotein complex.","method":"cDNA expression library immunoscreening; inhibition ELISA; immunoprecipitation of tRNA(Ser)Sec from cell extracts with eluted antibodies","journal":"Clinical and experimental immunology","confidence":"High","confidence_rationale":"Tier 2 — independent isolation by multiple groups using immunoscreening plus functional immunoprecipitation of the native tRNA complex","pmids":["10931155","10801173"],"is_preprint":false},{"year":2009,"finding":"The native SEPSECS protein in human hepatic cell extracts has an apparent molecular weight of 52 kDa, as determined by immunoaffinity chromatography followed by mass spectrometry identification, confirming the identity of the recombinant antigen with the endogenous protein.","method":"Immunoaffinity chromatography; mass spectrometry; monoclonal antibody validation","journal":"Journal of autoimmunity","confidence":"Medium","confidence_rationale":"Tier 2 — mass spectrometry-based identification of native protein from purified liver cell extract, single lab","pmids":["19683415"],"is_preprint":false},{"year":2012,"finding":"In the chicken brain, selenium supplementation increases SEPSECS mRNA levels and extends SEPSECS mRNA half-life, whereas selenium does not alter SEPSECS mRNA levels in cultured neurons. This indicates that selenium regulates SEPSECS expression post-transcriptionally (mRNA stability) in the avian brain, positioning SEPSECS as part of a selenium homeostasis feedback mechanism.","method":"Se supplementation in vivo and in cultured neurons; mRNA stability assays; quantitative RT-PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — direct measurement of mRNA half-life change as function of selenium; ortholog (chicken) consistent with mammalian SEPSECS function","pmids":["22536434"],"is_preprint":false}],"current_model":"SEPSECS is a pyridoxal phosphate-dependent enzyme that functions as a homotetramer to catalyze the final step of selenocysteine biosynthesis: it converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) using selenophosphate as the selenium donor, with tRNA(Sec) binding inducing a conformational change in the active site that enables substrate discrimination; SEPSECS physically interacts with SECp43 and selenophosphate synthetases (SEPHS1/2) in a multiprotein complex, and SECp43 regulates its nucleocytoplasmic shuttling and tRNA(Sec) methylation required for full selenoprotein expression; loss-of-function mutations in SEPSECS abolish selenoprotein synthesis and cause progressive cerebellocerebral atrophy and related encephalopathies in humans."},"narrative":{"teleology":[{"year":2000,"claim":"Identification of SEPSECS as the protein component of the tRNA(Ser)Sec ribonucleoprotein complex resolved the molecular identity of the SLA/LP autoantigen in autoimmune hepatitis and placed the protein within the selenocysteine biosynthesis machinery.","evidence":"cDNA expression library immunoscreening; immunoprecipitation of tRNA(Ser)Sec from HeLa cell extracts with eluted antibodies","pmids":["10931155","10801173"],"confidence":"High","gaps":["Enzymatic function of the protein not yet demonstrated","Relationship between autoantigenicity and catalytic role unknown"]},{"year":2005,"claim":"Demonstrating that SEPSECS forms a complex with SECp43 and tRNA(Sec), and that SECp43 controls SEPSECS nuclear translocation and tRNA(Sec) methylation, established the regulatory context in which SEPSECS operates before its catalytic role was formally proven.","evidence":"RNA interference knockdown; co-immunoprecipitation; subcellular fractionation in mammalian cells","pmids":["16230358"],"confidence":"High","gaps":["Mechanism by which SECp43 promotes nuclear import of SEPSECS not defined","Relative contributions of cytoplasmic vs. nuclear SEPSECS pools to selenoprotein synthesis unknown"]},{"year":2006,"claim":"In vitro reconstitution and in vivo complementation proved that SEPSECS is the eukaryotic/archaeal Sec synthase, resolving a long-standing gap in the selenocysteine biosynthetic pathway.","evidence":"Purified recombinant enzyme assay converting Sep-tRNA(Sec) to Sec-tRNA(Sec); complementation of E. coli SelA deletion","pmids":["17142313"],"confidence":"High","gaps":["Structural basis for substrate recognition not yet determined","Selenium donor specificity not fully resolved"]},{"year":2007,"claim":"Defining the obligatory substrate requirements—O-phosphoseryl-tRNA(Sec) rather than free phosphoserine, and selenophosphate as the selenium donor—established the two-component specificity of the SEPSECS reaction.","evidence":"Full reconstitution with purified tRNA, PSTK, SEPSECS, and selenophosphate synthetase; substrate specificity assays","pmids":["17194211"],"confidence":"High","gaps":["Kinetic parameters and rate-limiting step not characterized","Whether selenophosphate is directly transferred or proceeds via intermediate unknown"]},{"year":2009,"claim":"The crystal structure of the SEPSECS–tRNA(Sec) complex revealed the homotetrameric architecture, the PLP-dependent mechanism, and the tRNA-induced conformational change that enforces substrate discrimination, providing an atomic-level explanation for the tRNA-dependent catalysis.","evidence":"X-ray crystallography of human SEPSECS with tRNA(Sec), phosphoserine, and thiophosphate; complementary in vivo and in vitro enzyme assays","pmids":["19608919"],"confidence":"High","gaps":["No structure of the selenophosphate-bound intermediate captured","Dynamics of the conformational switch not resolved at the time-resolved level"]},{"year":2010,"claim":"Identification of homozygous loss-of-function SEPSECS mutations as the cause of progressive cerebellocerebral atrophy proved the enzyme is essential for selenoprotein synthesis and normal brain development in humans.","evidence":"Homozygosity mapping and sequencing in consanguineous families; clinical phenotyping","pmids":["20920667"],"confidence":"High","gaps":["Specific selenoproteins whose loss drives cerebellar neurodegeneration not identified","No animal model recapitulating PCCA phenotype described at this point"]},{"year":2015,"claim":"Characterization of hypomorphic SEPSECS mutations extended the genotype-phenotype spectrum, showing that partial enzyme activity leads to reduced but not absent selenoprotein synthesis with elevated oxidative damage, linking disease severity to residual catalytic capacity.","evidence":"Whole-exome sequencing; bacterial complementation assay; mass spectrometry and protein oxidation analysis of patient brain tissue","pmids":["26115735"],"confidence":"High","gaps":["Quantitative relationship between residual SEPSECS activity and selenoprotein output not determined","Contribution of oxidative damage versus specific selenoprotein loss to neuropathology not dissected"]},{"year":2017,"claim":"BRET and co-immunoprecipitation data showed that SEPSECS forms oligomeric assemblies with SEPHS1 and SEPHS2 in cells, extending the interaction network beyond the previously described SECp43 partnership and suggesting a selenocysteine biosynthesis supramolecular complex.","evidence":"BRET assay and co-immunoprecipitation in mammalian cells","pmids":["28414460"],"confidence":"Medium","gaps":["Functional consequence of SEPSECS–SEPHS1/2 interaction on catalytic efficiency not measured","Stoichiometry and architecture of the full complex not resolved","Findings from a single laboratory"]},{"year":null,"claim":"Key open questions include the structure of a catalytic intermediate with selenophosphate bound, the identity of the specific selenoproteins whose loss drives cerebellar neurodegeneration, and whether the SEPSECS–SEPHS–SECp43 supramolecular complex channels selenophosphate directly to the active site.","evidence":"","pmids":[],"confidence":"Low","gaps":["No selenophosphate-bound catalytic intermediate structure","Selenoprotein-specific contributions to PCCA neuropathology unresolved","Substrate channeling within the multiprotein complex not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,1,2]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,2,4]}],"complexes":["Selenocysteine biosynthesis complex (SEPSECS–SECp43–SEPHS1–SEPHS2)"],"partners":["TRNAU1AP","SEPHS1","SEPHS2"],"other_free_text":[]},"mechanistic_narrative":"SEPSECS is the pyridoxal phosphate-dependent enzyme that catalyzes the final step of selenocysteine (Sec) biosynthesis, converting O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) using selenophosphate as the selenium donor [PMID:17142313, PMID:17194211]. The crystal structure of the human enzyme reveals a homotetrameric architecture in which tRNA(Sec) binding—through its distinctive 13-bp acceptor-TΨC arm—induces an active-site conformational change that orients the phosphoseryl moiety for catalysis, thereby enforcing strict substrate discrimination against free phosphoserine [PMID:19608919]. SEPSECS resides in a multiprotein complex with SECp43, SEPHS1, and SEPHS2; SECp43 promotes nucleocytoplasmic shuttling of SEPSECS and is required for full tRNA(Sec) methylation and selenoprotein expression [PMID:16230358, PMID:28414460]. Loss-of-function mutations in SEPSECS abolish selenoprotein synthesis and cause autosomal-recessive progressive cerebellocerebral atrophy (PCCA) and related encephalopathies [PMID:20920667, PMID:26115735]."},"prefetch_data":{"uniprot":{"accession":"Q9HD40","full_name":"O-phosphoseryl-tRNA(Sec) selenium transferase","aliases":["Liver-pancreas antigen","LP","SLA-p35","SLA/LP autoantigen","Selenocysteine synthase","Sec synthase","Selenocysteinyl-tRNA(Sec) synthase","Sep-tRNA:Sec-tRNA synthase","SepSecS","Soluble liver antigen","SLA","UGA suppressor tRNA-associated protein","tRNA(Ser/Sec)-associated antigenic protein"],"length_aa":501,"mass_kda":55.7,"function":"Converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) required for selenoprotein biosynthesis","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9HD40/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SEPSECS","classification":"Not Classified","n_dependent_lines":690,"n_total_lines":1208,"dependency_fraction":0.5711920529801324},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SEPSECS","total_profiled":1310},"omim":[{"mim_id":"619597","title":"tRNA SELENOCYSTEINE 1-ASSOCIATED PROTEIN 1; TRNAU1AP","url":"https://www.omim.org/entry/619597"},{"mim_id":"613811","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D","url":"https://www.omim.org/entry/613811"},{"mim_id":"613009","title":"O-PHOSPHOSERINE tRNA-SELENOCYSTEINE tRNA SYNTHASE; SEPSECS","url":"https://www.omim.org/entry/613009"},{"mim_id":"607596","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A","url":"https://www.omim.org/entry/607596"},{"mim_id":"277470","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A","url":"https://www.omim.org/entry/277470"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"liver","ntpm":24.4}],"url":"https://www.proteinatlas.org/search/SEPSECS"},"hgnc":{"alias_symbol":["SLA/LP","SLA","SLA-p35","SecS"],"prev_symbol":[]},"alphafold":{"accession":"Q9HD40","domains":[{"cath_id":"1.10.10.2160","chopping":"4-67_79-89","consensus_level":"medium","plddt":96.4603,"start":4,"end":89},{"cath_id":"3.40.640.10","chopping":"110-331","consensus_level":"medium","plddt":98.545,"start":110,"end":331},{"cath_id":"3.90.1150.10","chopping":"335-468","consensus_level":"medium","plddt":94.5366,"start":335,"end":468}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HD40","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HD40-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HD40-F1-predicted_aligned_error_v6.png","plddt_mean":92.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SEPSECS","jax_strain_url":"https://www.jax.org/strain/search?query=SEPSECS"},"sequence":{"accession":"Q9HD40","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HD40.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HD40/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HD40"}},"corpus_meta":[{"pmid":"9988272","id":"PMC_9988272","title":"Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9988272","citation_count":822,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11952734","id":"PMC_11952734","title":"The use of reduced healing times on ITI implants with a sandblasted and acid-etched (SLA) surface: early results from clinical trials on ITI SLA implants.","date":"2002","source":"Clinical oral implants research","url":"https://pubmed.ncbi.nlm.nih.gov/11952734","citation_count":428,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10801173","id":"PMC_10801173","title":"Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.","date":"2000","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10801173","citation_count":221,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28114170","id":"PMC_28114170","title":"Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs.","date":"2017","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/28114170","citation_count":190,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18760302","id":"PMC_18760302","title":"Molecular genetics of the swine major histocompatibility complex, the SLA complex.","date":"2008","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18760302","citation_count":146,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29263911","id":"PMC_29263911","title":"Let's talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine.","date":"2017","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29263911","citation_count":137,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12117891","id":"PMC_12117891","title":"Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics.","date":"2002","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/12117891","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19608919","id":"PMC_19608919","title":"The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation.","date":"2009","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/19608919","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7912457","id":"PMC_7912457","title":"Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.","date":"1994","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/7912457","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21679736","id":"PMC_21679736","title":"Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells.","date":"2011","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/21679736","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15713212","id":"PMC_15713212","title":"Nomenclature for factors of the SLA class-I system, 2004.","date":"2005","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/15713212","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18458368","id":"PMC_18458368","title":"The biocompatibility of SLA-treated titanium implants.","date":"2008","source":"Biomedical materials (Bristol, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18458368","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28293634","id":"PMC_28293634","title":"SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis.","date":"2017","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/28293634","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24367103","id":"PMC_24367103","title":"AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24367103","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23560589","id":"PMC_23560589","title":"Osteoblastic and osteoclastic differentiation on SLA and hydrophilic modified SLA titanium surfaces.","date":"2013","source":"Clinical oral implants research","url":"https://pubmed.ncbi.nlm.nih.gov/23560589","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8593613","id":"PMC_8593613","title":"Directed integration of the physical and genetic linkage maps of swine chromosome 7 reveals that the SLA spans the centromere.","date":"1995","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8593613","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11230739","id":"PMC_11230739","title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.","date":"2001","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11230739","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15693842","id":"PMC_15693842","title":"Rapid assignment of the swine major histocompatibility complex (SLA) class I and II genotypes in Clawn miniature swine using PCR-SSP and PCR-RFLP methods.","date":"2005","source":"Xenotransplantation","url":"https://pubmed.ncbi.nlm.nih.gov/15693842","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25113420","id":"PMC_25113420","title":"Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.","date":"2014","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/25113420","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23827608","id":"PMC_23827608","title":"Mg ion implantation on SLA-treated titanium surface and its effects on the behavior of mesenchymal stem cell.","date":"2012","source":"Materials science & engineering. C, Materials for biological applications","url":"https://pubmed.ncbi.nlm.nih.gov/23827608","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2783490","id":"PMC_2783490","title":"Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2783490","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30951017","id":"PMC_30951017","title":"HLA Class I-sensitized Renal Transplant Patients Have Antibody Binding to SLA Class I Epitopes.","date":"2019","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/30951017","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30192064","id":"PMC_30192064","title":"Multifunctional effects of a modification of SLA titanium implant surface with strontium-containing nanostructures on immunoinflammatory and osteogenic cell function.","date":"2018","source":"Journal of biomedical materials research. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30192064","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34750472","id":"PMC_34750472","title":"Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34750472","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31733031","id":"PMC_31733031","title":"Triple (GGTA1, CMAH, B2M) modified pigs expressing an SLA class Ilow phenotype-Effects on immune status and susceptibility to human immune responses.","date":"2019","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/31733031","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12765473","id":"PMC_12765473","title":"Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.","date":"2002","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/12765473","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7537478","id":"PMC_7537478","title":"Polymerase chain reaction based genotyping for characterization of SLA-DQB and SLA-DRB alleles in domestic pigs.","date":"1995","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7537478","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28395176","id":"PMC_28395176","title":"The ketogenic diet metabolite beta-hydroxybutyrate (β-HB) reduces incidence of seizure-like activity (SLA) in a Katp- and GABAb-dependent manner in a whole-animal Drosophila melanogaster model.","date":"2017","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/28395176","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16202982","id":"PMC_16202982","title":"Rat sinusoidal liver endothelial cells (SECs) produce pro-fibrotic factors in response to adducts formed from the metabolites of ethanol.","date":"2005","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16202982","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22223037","id":"PMC_22223037","title":"Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis.","date":"2012","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/22223037","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26022509","id":"PMC_26022509","title":"Using a split luciferase assay (SLA) to measure the kinetics of cell-cell fusion mediated by herpes simplex virus glycoproteins.","date":"2015","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/26022509","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19782700","id":"PMC_19782700","title":"Swine leukocyte antigen (SLA) diversity in Sinclair and Hanford swine.","date":"2009","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19782700","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"708646","id":"PMC_708646","title":"Iron deficiency anaemia in newborn sla mice: a genetic defect of placental iron transport.","date":"1978","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/708646","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25246326","id":"PMC_25246326","title":"Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis.","date":"2014","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25246326","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14673549","id":"PMC_14673549","title":"Nucleotide sequencing analysis of the swine 433-kb genomic segment located between the non-classical and classical SLA class I gene clusters.","date":"2003","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/14673549","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23760881","id":"PMC_23760881","title":"Effects of Er: YAG laser irradiation on wettability, surface roughness, and biocompatibility of SLA titanium surfaces: an in vitro study.","date":"2013","source":"Lasers in medical science","url":"https://pubmed.ncbi.nlm.nih.gov/23760881","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22536434","id":"PMC_22536434","title":"Priority in selenium homeostasis involves regulation of SepSecS transcription in the chicken brain.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22536434","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2513834","id":"PMC_2513834","title":"Possible relationships between SLA and porcine reproduction.","date":"1989","source":"Reproduction, nutrition, development","url":"https://pubmed.ncbi.nlm.nih.gov/2513834","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16870265","id":"PMC_16870265","title":"Reconstruction of a swine SLA-I protein complex and determination of binding nonameric peptides derived from the foot-and-mouth disease virus.","date":"2006","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/16870265","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6800077","id":"PMC_6800077","title":"Transplantation in miniature swine. X. Evidence for non-SLA-linked immune response gene(s) controlling rejection of SLA-matched kidney allografts.","date":"1981","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/6800077","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25990845","id":"PMC_25990845","title":"PRRSV-infected monocyte-derived dendritic cells express high levels of SLA-DR and CD80/86 but do not stimulate PRRSV-naïve regulatory T cells to proliferate.","date":"2015","source":"Veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/25990845","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31149350","id":"PMC_31149350","title":"The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine.","date":"2019","source":"NPJ vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/31149350","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12892738","id":"PMC_12892738","title":"Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay.","date":"2003","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/12892738","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2729673","id":"PMC_2729673","title":"The swine leucocyte antigen (SLA) complex and Sinclair swine cutaneous malignant melanoma.","date":"1989","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2729673","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10595417","id":"PMC_10595417","title":"A selective genetic analysis of the Syracuse high- and low-avoidance (SHA/Bru and SLA/Bru) strains of rats (Rattus norvegicus).","date":"1999","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10595417","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9027749","id":"PMC_9027749","title":"The SLA RNA gene of Trypanosoma brucei is organized in a tandem array which encodes several small RNAs.","date":"1996","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/9027749","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19152667","id":"PMC_19152667","title":"Assignment of the SLA alleles and reproductive potential of selective breeding Duroc pig lines.","date":"2008","source":"Xenotransplantation","url":"https://pubmed.ncbi.nlm.nih.gov/19152667","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1543900","id":"PMC_1543900","title":"Mapping of the SLA complex of miniature swine: mapping of the SLA gene complex by pulsed field gel electrophoresis.","date":"1992","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/1543900","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19683415","id":"PMC_19683415","title":"SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.","date":"2009","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/19683415","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35498250","id":"PMC_35498250","title":"The FAST Pump, a low-cost, easy to fabricate, SLA-3D-printed peristaltic pump for multi-channel systems in any lab.","date":"2020","source":"HardwareX","url":"https://pubmed.ncbi.nlm.nih.gov/35498250","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32764551","id":"PMC_32764551","title":"Identification of the viral RNA promoter stem loop A (SLA)-binding site on Zika virus polymerase NS5.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32764551","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26418567","id":"PMC_26418567","title":"Early bone response to machined, sandblasting acid etching (SLA) and novel surface-functionalization (SLAffinity) titanium implants: characterization, biomechanical analysis and histological evaluation in pigs.","date":"2015","source":"Journal of biomedical materials research. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26418567","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11896343","id":"PMC_11896343","title":"Expansion of the Knops blood group system and subdivision of Sl(a).","date":"2002","source":"Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/11896343","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18549392","id":"PMC_18549392","title":"Sequence-based characterization of the eight SLA loci in Korean native pigs.","date":"2008","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/18549392","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28414460","id":"PMC_28414460","title":"Analysis of Novel Interactions between Components of the Selenocysteine Biosynthesis Pathway, SEPHS1, SEPHS2, SEPSECS, and SECp43.","date":"2017","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28414460","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32796065","id":"PMC_32796065","title":"Porcine Reproductive and Respiratory Syndrome Virus Promotes SLA-DR-Mediated Antigen Presentation of Nonstructural Proteins To Evoke a Nonneutralizing Antibody Response In Vivo.","date":"2020","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/32796065","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27150838","id":"PMC_27150838","title":"SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKCβ.","date":"2016","source":"Pathogens and disease","url":"https://pubmed.ncbi.nlm.nih.gov/27150838","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3141620","id":"PMC_3141620","title":"Influence of SLA haplotype on preimplantation embryonic cell number in miniature pigs.","date":"1988","source":"Journal of reproduction and fertility","url":"https://pubmed.ncbi.nlm.nih.gov/3141620","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34835070","id":"PMC_34835070","title":"Evaluation of Cellular Immunity with ASFV Infection by Swine Leukocyte Antigen (SLA)-Peptide Tetramers.","date":"2021","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/34835070","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19631983","id":"PMC_19631983","title":"Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia.","date":"2009","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/19631983","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29222521","id":"PMC_29222521","title":"Cytokines and chemokines measured in dried SLA-stimulated whole blood spots for asymptomatic Leishmania infantum and Leishmania donovani infection.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29222521","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22984928","id":"PMC_22984928","title":"Identification of peptides from foot-and-mouth disease virus structural proteins bound by class I swine leukocyte antigen (SLA) alleles, SLA-1*0401 and SLA-2*0401.","date":"2012","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22984928","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11943330","id":"PMC_11943330","title":"Development of a rapid in vitro protein refolding assay which discriminates between peptide-bound and peptide-free forms of recombinant porcine major histocompatibility class I complex (SLA-I).","date":"2002","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/11943330","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2515776","id":"PMC_2515776","title":"Genetic and other effects on bacterial phagocytosis and killing by cultured peripheral blood monocytes of SLA-defined miniature pigs.","date":"1989","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2515776","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6177778","id":"PMC_6177778","title":"Transplantation in miniature swine. XII. N-terminal sequences of class I histocompatibility antigens (SLA) and beta 2-microglobulin.","date":"1982","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/6177778","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31969884","id":"PMC_31969884","title":"Illumination of PRRSV Cytotoxic T Lymphocyte Epitopes by the Three-Dimensional Structure and Peptidome of Swine Lymphocyte Antigen Class I (SLA-I).","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31969884","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20604896","id":"PMC_20604896","title":"Simple and comprehensive SLA-DQB1 genotyping using genomic PCR and direct sequencing.","date":"2010","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/20604896","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31959823","id":"PMC_31959823","title":"SLA-1 Genetic Diversity in Pigs: Extensive Analysis of Copy Number Variation, Heterozygosity, Expression, and Breed Specificity.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31959823","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8363104","id":"PMC_8363104","title":"Common swine leucocyte antigen (SLA) haplotypes in NIH and Sinclair miniature swine have similar effects on the expression of an inherited melanoma.","date":"1993","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8363104","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27693332","id":"PMC_27693332","title":"Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients.","date":"2016","source":"Acta tropica","url":"https://pubmed.ncbi.nlm.nih.gov/27693332","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15118849","id":"PMC_15118849","title":"Sequence and mRNA expression of nonclassical SLA class I genes SLA-7 and SLA-8.","date":"2004","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/15118849","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16189668","id":"PMC_16189668","title":"Development of dense microsatellite markers in the entire SLA region and evaluation of their polymorphisms in porcine breeds.","date":"2005","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/16189668","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20623998","id":"PMC_20623998","title":"Human SepSecS or SLA/LP: selenocysteine formation and autoimmune hepatitis.","date":"2010","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20623998","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29464431","id":"PMC_29464431","title":"A SEPSECS mutation in a 23-year-old woman with microcephaly and progressive cerebellar ataxia.","date":"2018","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/29464431","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29326671","id":"PMC_29326671","title":"Specificity Characterization of SLA Class I Molecules Binding to Swine-Origin Viral Cytotoxic T Lymphocyte Epitope Peptides in Vitro.","date":"2017","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29326671","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37604847","id":"PMC_37604847","title":"The non-classical major histocompatibility complex II protein SLA-DM is crucial for African swine fever virus replication.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37604847","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36868181","id":"PMC_36868181","title":"Osteogenic and anti-inflammatory effects of SLA titanium substrates doped with chitosan-stabilized selenium nanoparticles via a covalent coupling strategy.","date":"2023","source":"Colloids and surfaces. B, Biointerfaces","url":"https://pubmed.ncbi.nlm.nih.gov/36868181","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26382972","id":"PMC_26382972","title":"Improved osseointegration of long-term stored SLA implant by hydrothermal sterilization.","date":"2015","source":"Journal of the mechanical behavior of biomedical materials","url":"https://pubmed.ncbi.nlm.nih.gov/26382972","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9504898","id":"PMC_9504898","title":"Antibodies to P450IID6, SLA, PDH-E2 and BCKD-E2 in Japanese patients with chronic hepatitis.","date":"1997","source":"Journal of gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/9504898","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22213622","id":"PMC_22213622","title":"Evaluation of chemically modified SLA implants (modSLA) biofunctionalized with integrin (RGD)- and heparin (KRSR)-binding peptides.","date":"2011","source":"Journal of biomedical materials research. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22213622","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23575112","id":"PMC_23575112","title":"Structural mimicry between SLA/LP and Rickettsia surface antigens as a driver of autoimmune hepatitis: insights from an in silico study.","date":"2013","source":"Theoretical biology & medical modelling","url":"https://pubmed.ncbi.nlm.nih.gov/23575112","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23139801","id":"PMC_23139801","title":"Prediction of altered 3'- UTR miRNA-binding sites from RNA-Seq data: the swine leukocyte antigen complex (SLA) as a model region.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23139801","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26634489","id":"PMC_26634489","title":"Swine leukocyte antigen class II genes (SLA-DRA, SLA-DRB1, SLA-DQA, SLA-DQB1) polymorphism and genotyping in Guizhou minipigs.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26634489","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34771869","id":"PMC_34771869","title":"Critical Role of Etching Parameters in the Evolution of Nano Micro SLA Surface on the Ti6Al4V Alloy Dental Implants.","date":"2021","source":"Materials (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34771869","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34858400","id":"PMC_34858400","title":"Porcine Epidemic Diarrhea Virus Envelope Protein Blocks SLA-DR Expression in Barrow-Derived Dendritic Cells by Inhibiting Promoters Activation.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34858400","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33195147","id":"PMC_33195147","title":"Human Salivary Histatin-1 Promotes Osteogenic Cell Spreading on Both Bio-Inert Substrates and Titanium SLA Surfaces.","date":"2020","source":"Frontiers in bioengineering and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/33195147","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15935298","id":"PMC_15935298","title":"Novel SLA-DQ alleles and their recombinant molecules in xenogeneic stimulation of human T cells.","date":"2005","source":"Transplant immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15935298","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27881639","id":"PMC_27881639","title":"Enhancement of osseointegration by direct coating of rhBMP-2 on target-ion induced plasma sputtering treated SLA surface for dental application.","date":"2016","source":"Journal of biomaterials applications","url":"https://pubmed.ncbi.nlm.nih.gov/27881639","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10502496","id":"PMC_10502496","title":"DNA profiling reveals remarkably low genetic variability in a herd of SLA homozygous pigs.","date":"1999","source":"Research in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/10502496","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38394240","id":"PMC_38394240","title":"A neural pathway for social modulation of spontaneous locomotor activity (SoMo-SLA) in Drosophila.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38394240","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11214013","id":"PMC_11214013","title":"Influence of glutaraldehyde fixation on the detection of SLA-I and II antigens and calcification tendency in porcine cardiac tissue.","date":"2000","source":"Scandinavian cardiovascular journal : SCJ","url":"https://pubmed.ncbi.nlm.nih.gov/11214013","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2874831","id":"PMC_2874831","title":"Relationship between anemia and cholesterol metabolism in 'sex-linked anemic' (gene symbol, sla) mouse.","date":"1986","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/2874831","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7687468","id":"PMC_7687468","title":"Characterization of a polymorphic heat shock protein 70 gene in swine outside the SLA major histocompatibility complex.","date":"1993","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/7687468","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32911818","id":"PMC_32911818","title":"Association of Porcine Swine Leukocyte Antigen (SLA) Haplotypes with B- and T-Cell Immune Response to Foot-and-Mouth Disease Virus (FMDV) Peptides.","date":"2020","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/32911818","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35497867","id":"PMC_35497867","title":"Biocorrosion of pure and SLA titanium surfaces in the presence of Porphyromonas gingivalis and its effects on osteoblast behavior.","date":"2020","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/35497867","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35424597","id":"PMC_35424597","title":"Antimicrobial peptide GL13K immobilized onto SLA-treated titanium by silanization: antibacterial effect against methicillin-resistant Staphylococcus aureus (MRSA).","date":"2022","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/35424597","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30011802","id":"PMC_30011802","title":"Impact of Nano-Crystalline Diamond Enhanced Hydrophilicity on Cell Proliferation on Machined and SLA Titanium Surfaces: An In-Vivo Study in Rodents.","date":"2018","source":"Nanomaterials (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/30011802","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16219170","id":"PMC_16219170","title":"Novel SLA-DR alleles of three Chinese pig strains and the related function in human T cell response.","date":"2004","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16219170","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29607698","id":"PMC_29607698","title":"The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome.","date":"2018","source":"Artificial cells, nanomedicine, and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/29607698","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12974618","id":"PMC_12974618","title":"Novel SLA class I alleles of Chinese pig strains and their significance in xenotransplantation.","date":"2003","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12974618","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32353859","id":"PMC_32353859","title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32353859","citation_count":3411,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22190034","id":"PMC_22190034","title":"Global landscape of HIV-human protein complexes.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22190034","citation_count":593,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33060197","id":"PMC_33060197","title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33060197","citation_count":564,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15146197","id":"PMC_15146197","title":"Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15146197","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17194211","id":"PMC_17194211","title":"Biosynthesis of selenocysteine on its tRNA in eukaryotes.","date":"2007","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/17194211","citation_count":236,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17142313","id":"PMC_17142313","title":"RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17142313","citation_count":155,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25609649","id":"PMC_25609649","title":"Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.","date":"2015","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/25609649","citation_count":120,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20920667","id":"PMC_20920667","title":"Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20920667","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10931155","id":"PMC_10931155","title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis.","date":"2000","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10931155","citation_count":111,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28133863","id":"PMC_28133863","title":"Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression.","date":"2017","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28133863","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32707033","id":"PMC_32707033","title":"Kinase Interaction Network Expands Functional and Disease Roles of Human Kinases.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32707033","citation_count":88,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23667531","id":"PMC_23667531","title":"The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23667531","citation_count":85,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30561431","id":"PMC_30561431","title":"A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.","date":"2018","source":"Scientific data","url":"https://pubmed.ncbi.nlm.nih.gov/30561431","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16230358","id":"PMC_16230358","title":"Evidence for direct roles of two additional factors, SECp43 and soluble liver antigen, in the selenoprotein synthesis machinery.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16230358","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20471133","id":"PMC_20471133","title":"A combination of functional polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk of non-small cell lung cancer.","date":"2010","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/20471133","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26115735","id":"PMC_26115735","title":"Selenoprotein biosynthesis defect causes progressive encephalopathy with elevated lactate.","date":"2015","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26115735","citation_count":49,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11826415","id":"PMC_11826415","title":"Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.","date":"2002","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11826415","citation_count":46,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23112913","id":"PMC_23112913","title":"Selenium, selenoprotein genes and Crohn's disease in a case-control population from Auckland, New Zealand.","date":"2012","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/23112913","citation_count":41,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27432908","id":"PMC_27432908","title":"Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.","date":"2016","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/27432908","citation_count":36,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29845934","id":"PMC_29845934","title":"The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29845934","citation_count":31,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49338,"output_tokens":2008,"usd":0.089067},"stage2":{"model":"claude-opus-4-6","input_tokens":5304,"output_tokens":1812,"usd":0.10773},"total_usd":0.440446,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":62148,"output_tokens":2747,"usd":0.113824},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6305,"output_tokens":2201,"usd":0.129825}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"Human SepSecS (SEPSECS) is an O-phosphoseryl-tRNA:selenocysteinyl-tRNA synthase that catalyzes the final step of selenocysteine biosynthesis via a pyridoxal phosphate (PLP)-dependent mechanism. Crystal structure of human tRNA(Sec) in complex with SepSecS, phosphoserine, and thiophosphate revealed that two tRNA(Sec) molecules bind to each SepSecS tetramer through their 13-base pair acceptor-TPsiC arm. tRNA binding induces a conformational change in the active site that allows phosphoserine covalently attached to tRNA(Sec) — but not free phosphoserine — to be properly oriented for the reaction.\",\n      \"method\": \"Crystal structure determination combined with in vivo and in vitro enzyme assays and active-site characterization\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro, crystal structure with functional validation, active-site mechanism established in a single rigorous study\",\n      \"pmids\": [\"19608919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The SLA/LP autoantigen — later identified as SEPSECS — is a 422-amino acid protein (present in two splice variants) that is the sole target antigen of SLA/LP autoantibodies in autoimmune hepatitis. Amino acids 371–409 were identified as critical for immune recognition by deletion mutant mapping.\",\n      \"method\": \"cDNA expression library immunoscreening with autoimmune sera, inhibition ELISA, deletion mutant epitope mapping\",\n      \"journal\": \"Lancet\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (expression cloning, absorption experiments, deletion mapping) in a single study; foundational identification paper\",\n      \"pmids\": [\"10801173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A recombinant 35-kDa truncated form of the SEPSECS protein (SLA-p35) was isolated from a human liver gene expression library and shown to contain the major but not sole antigenic component of soluble liver antigen, with strong homology to a UGA serine tRNA-protein complex-related protein.\",\n      \"method\": \"Immunoscreening of human liver cDNA expression library, immunoblot, polyclonal inhibition ELISA\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal immunoblot and inhibition assay; single lab but orthogonal methods\",\n      \"pmids\": [\"11230739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The native human SEPSECS protein present in human hepatic cell extract has a molecular weight of 52 kDa (as the major antigenic species), confirmed by immune affinity chromatography and mass spectrometry identification of the purification product. A monoclonal antibody generated against recombinant SLA-p35 confirmed identity of the recombinant and native proteins.\",\n      \"method\": \"Immune affinity chromatography, mass spectrometry, monoclonal antibody generation and immunoblot\",\n      \"journal\": \"Journal of autoimmunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — native protein purified from human liver cells and identified by mass spectrometry with antibody confirmation; strong evidence for native form\",\n      \"pmids\": [\"19683415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SEPSECS forms oligomers in eukaryotic cells and interacts with SECp43, SEPHS1, and SEPHS2 as part of the selenocysteine biosynthesis and incorporation machinery. SEPHS2 interacts with SEPSECS and SEPHS1; these interactions were confirmed by co-immunoprecipitation. BRET assays in mammalian cells established that SEPSECS forms oligomers with these partners.\",\n      \"method\": \"Bioluminescence resonance energy transfer (BRET) assay in mammalian cells, co-immunoprecipitation, small-angle X-ray scattering of SECp43, phage display for interaction site mapping\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP and BRET with multiple orthogonal methods in a single lab study\",\n      \"pmids\": [\"28414460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SepSecS mRNA levels are regulated by selenium (Se) availability in the chicken brain: Se supplementation increases SepSecS mRNA in brain tissue, and Se alters SepSecS mRNA stability (half-life) in primary neurons, indicating a post-transcriptional regulatory mechanism controlling SepSecS expression during selenium homeostasis.\",\n      \"method\": \"In vivo Se supplementation in chickens, primary neuronal cell culture, mRNA stability (half-life) measurement\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct mRNA stability assay combined with in vivo tissue measurements; single lab, two orthogonal approaches (in vivo and in vitro)\",\n      \"pmids\": [\"22536434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A homozygous missense mutation in SEPSECS (c.1321G>A; p.Gly441Arg) causes a milder form of pontocerebellar hypoplasia/cerebellar ataxia with cognitive impairment presenting at age 23, establishing SEPSECS loss-of-function as causative for neurodegeneration beyond the severe infantile phenotype.\",\n      \"method\": \"Whole exome sequencing, clinical phenotyping of patient with SEPSECS mutation\",\n      \"journal\": \"Journal of inherited metabolic disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — genetic identification only; no direct biochemical or cell biological mechanistic follow-up in this paper\",\n      \"pmids\": [\"29464431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Human SepSecS converts phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) as the final step of selenocysteine (Sec) formation in a tRNA-dependent, PLP-dependent reaction. The protein is identical to the SLA/LP autoantigen of autoimmune hepatitis, linking selenium metabolism to autoimmunity.\",\n      \"method\": \"Biochemical review integrating crystal structure, in vitro enzyme assays, and immunological data from prior studies\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — consolidates crystal structure and enzymatic data; replicated across labs (Söll, Simonovic, and Lohse groups)\",\n      \"pmids\": [\"20623998\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SEPSECS is a homotetrameric, pyridoxal phosphate-dependent enzyme that catalyzes the final step of selenocysteine biosynthesis by converting O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec); two tRNA(Sec) molecules bind per tetramer through their acceptor-TPsiC arm, inducing an active-site conformational change that selectively accommodates the tRNA-linked phosphoserine substrate, and SEPSECS additionally forms oligomeric complexes with SECp43, SEPHS1, and SEPHS2 within the broader selenocysteine incorporation machinery.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"SEPSECS (then annotated as SLA/LP) catalyzes the tRNA-dependent conversion of O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) in eukaryotes and archaea. Purified recombinant SepSecS converts Sep-tRNA(Sec) into Sec-tRNA(Sec) in vitro in the presence of sodium selenite and selenophosphate synthetase. Human and archaeal SepSecS genes complement an E. coli SelA deletion strain in vivo, establishing SepSecS as the eukaryotic/archaeal Sec synthase.\",\n      \"method\": \"In vitro enzyme assay with purified recombinant protein; in vivo complementation of E. coli SelA deletion strain\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution plus in vivo complementation, replicated by independent groups\",\n      \"pmids\": [\"17142313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SEPSECS (SecS/soluble liver antigen) requires O-phosphoseryl-tRNA([Ser]Sec) as its obligatory substrate (not free phosphoserine or seryl-tRNA), and requires selenophosphate as the selenium donor, to generate selenocysteyl-tRNA([Ser]Sec). This establishes the two-component substrate requirement for SecS activity.\",\n      \"method\": \"In vitro biochemical reconstitution with purified components (tRNA, PSTK, SEPSECS, selenophosphate synthetase); substrate specificity assays\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — full reconstitution of the Sec biosynthesis pathway with defined purified components, replicated across studies\",\n      \"pmids\": [\"17194211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of human SepSecS (SLA/LP) in complex with tRNA(Sec), phosphoserine, and thiophosphate reveals: (1) SepSecS functions as a tetramer; (2) two tRNA(Sec) molecules bind per tetramer through their 13-bp acceptor-TΨC arm, which has a fold distinct from canonical tRNAs; (3) tRNA binding induces a conformational change in the active site that correctly orients phosphoserine covalently attached to tRNA(Sec) but not free phosphoserine; (4) the reaction proceeds via a pyridoxal phosphate-dependent mechanism.\",\n      \"method\": \"X-ray crystallography; in vivo and in vitro enzyme assays; active-site analysis\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic-resolution crystal structure combined with in vivo and in vitro functional assays in a single rigorous study\",\n      \"pmids\": [\"19608919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SLA (SEPSECS) forms a multiprotein complex with SECp43 and tRNA([Ser]Sec) in cells. Knockdown of SECp43 reduces tRNA(Sec) wobble-position methylation (Um34) and decreases selenoprotein expression; double knockdown of SECp43 and SLA further reduces selenoprotein expression. SECp43 and SLA each affect the other's binding to tRNA(Sec). SLA is located primarily in the cytoplasm, but co-transfection with SECp43 causes nuclear translocation of SLA, indicating SECp43 promotes nucleocytoplasmic shuttling of SLA.\",\n      \"method\": \"RNA interference knockdown; co-immunoprecipitation; subcellular fractionation/localization; selenoprotein expression assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction and localization validated by multiple orthogonal methods (RNAi, co-IP, fractionation) with defined functional readouts\",\n      \"pmids\": [\"16230358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Loss-of-function mutations in SEPSECS cause autosomal-recessive progressive cerebellocerebral atrophy (PCCA) in humans. Both founder mutations (in Iraqi and Moroccan Jewish populations) disrupt the sole route to selenocysteine biosynthesis and thus abolish selenoprotein synthesis, establishing SEPSECS as an essential enzyme in vivo for selenoprotein generation and brain function.\",\n      \"method\": \"Human genetics (homozygosity mapping, sequencing); functional inference from established SEPSECS enzymatic role\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human loss-of-function variants with defined molecular mechanism (abolished Sec synthesis) and clinical phenotype, corroborated by known biochemistry\",\n      \"pmids\": [\"20920667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Compound heterozygous SEPSECS mutations (p.Thr325Ser and p.Tyr429*) do not completely abolish enzyme activity but lead to decreased selenoprotein levels and increased oxidative protein damage in patient brain tissue, extending the phenotypic spectrum of SEPSECS deficiency to a progressive encephalopathy with elevated lactate. A bacterial activity assay confirmed that the missense mutation partially impairs but does not eliminate SEPSECS function.\",\n      \"method\": \"Whole-exome sequencing; bacterial complementation activity assay; mass spectrometry; Western blotting; protein oxidation detection\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — bacterial activity assay plus multiple biochemical assays on patient tissue; mechanistic link between hypomorphic mutations and partial loss of selenoprotein synthesis established\",\n      \"pmids\": [\"26115735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SEPSECS, SECp43, SEPHS1, and SEPHS2 form oligomers in eukaryotic cells. SEPHS2 interacts with SEPSECS and SEPHS1; these interactions were confirmed by bioluminescence resonance energy transfer (BRET) assay and co-immunoprecipitation in mammalian cells.\",\n      \"method\": \"Bioluminescence resonance energy transfer (BRET) assay in mammalian cells; co-immunoprecipitation\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — two orthogonal methods (BRET and co-IP) from a single lab; interaction network defined but downstream functional consequences not fully resolved\",\n      \"pmids\": [\"28414460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The target antigen of SLA/LP autoantibodies in autoimmune hepatitis is a 422-amino-acid protein (SEPSECS/tRNP(Ser)Sec-associated protein). The protein was identified by cDNA expression library immunoscreening; antibodies eluted from the recombinant protein immunoprecipitate tRNA(Ser)Sec from HeLa cell extracts, demonstrating that the autoantigen is the protein component of the tRNA(Ser)Sec ribonucleoprotein complex.\",\n      \"method\": \"cDNA expression library immunoscreening; inhibition ELISA; immunoprecipitation of tRNA(Ser)Sec from cell extracts with eluted antibodies\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — independent isolation by multiple groups using immunoscreening plus functional immunoprecipitation of the native tRNA complex\",\n      \"pmids\": [\"10931155\", \"10801173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The native SEPSECS protein in human hepatic cell extracts has an apparent molecular weight of 52 kDa, as determined by immunoaffinity chromatography followed by mass spectrometry identification, confirming the identity of the recombinant antigen with the endogenous protein.\",\n      \"method\": \"Immunoaffinity chromatography; mass spectrometry; monoclonal antibody validation\",\n      \"journal\": \"Journal of autoimmunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mass spectrometry-based identification of native protein from purified liver cell extract, single lab\",\n      \"pmids\": [\"19683415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In the chicken brain, selenium supplementation increases SEPSECS mRNA levels and extends SEPSECS mRNA half-life, whereas selenium does not alter SEPSECS mRNA levels in cultured neurons. This indicates that selenium regulates SEPSECS expression post-transcriptionally (mRNA stability) in the avian brain, positioning SEPSECS as part of a selenium homeostasis feedback mechanism.\",\n      \"method\": \"Se supplementation in vivo and in cultured neurons; mRNA stability assays; quantitative RT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct measurement of mRNA half-life change as function of selenium; ortholog (chicken) consistent with mammalian SEPSECS function\",\n      \"pmids\": [\"22536434\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SEPSECS is a pyridoxal phosphate-dependent enzyme that functions as a homotetramer to catalyze the final step of selenocysteine biosynthesis: it converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) using selenophosphate as the selenium donor, with tRNA(Sec) binding inducing a conformational change in the active site that enables substrate discrimination; SEPSECS physically interacts with SECp43 and selenophosphate synthetases (SEPHS1/2) in a multiprotein complex, and SECp43 regulates its nucleocytoplasmic shuttling and tRNA(Sec) methylation required for full selenoprotein expression; loss-of-function mutations in SEPSECS abolish selenoprotein synthesis and cause progressive cerebellocerebral atrophy and related encephalopathies in humans.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SEPSECS is a pyridoxal phosphate (PLP)-dependent enzyme that catalyzes the final step of selenocysteine biosynthesis by converting O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) [PMID:19608919, PMID:20623998]. The enzyme functions as a homotetramer that binds two tRNA(Sec) molecules through their 13-base pair acceptor-TΨC arm, inducing an active-site conformational change that selectively accommodates the tRNA-linked phosphoserine substrate but not free phosphoserine [PMID:19608919]. SEPSECS forms oligomeric complexes with SECp43, SEPHS1, and SEPHS2 within the broader selenocysteine incorporation machinery [PMID:28414460]. Loss-of-function mutations in SEPSECS cause pontocerebellar hypoplasia and cerebellar ataxia with cognitive impairment, and the protein is the sole target antigen of SLA/LP autoantibodies in autoimmune hepatitis [PMID:29464431, PMID:10801173].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identifying SEPSECS as the SLA/LP autoantigen established that a single protein is the exclusive serological target in SLA/LP-positive autoimmune hepatitis, setting the stage for understanding its biological function.\",\n      \"evidence\": \"cDNA expression library immunoscreening with autoimmune sera, inhibition ELISA, and deletion mutant epitope mapping\",\n      \"pmids\": [\"10801173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic function unknown at this stage\", \"No structural information\", \"Mechanism linking this protein to liver autoimmunity not determined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Isolation of a truncated antigenic form from liver and its sequence homology to a UGA serine tRNA-associated protein provided the first hint that SEPSECS participates in selenocysteine/tRNA biology.\",\n      \"evidence\": \"Immunoscreening of human liver cDNA expression library, immunoblot, polyclonal inhibition ELISA\",\n      \"pmids\": [\"11230739\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct enzymatic assay performed\", \"Homology-based functional inference only\", \"Full-length native protein not characterized\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Determining the crystal structure of human SEPSECS in complex with tRNA(Sec), phosphoserine, and thiophosphate established the complete catalytic mechanism: a PLP-dependent, tRNA-dependent conversion of O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec), resolving the final step of selenocysteine biosynthesis.\",\n      \"evidence\": \"X-ray crystallography, in vivo and in vitro enzyme assays, active-site mutagenesis\",\n      \"pmids\": [\"19608919\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selenium donor identity in vivo not fully resolved\", \"Regulation of enzyme activity in cells unknown\", \"Mechanism of tRNA(Sec) selectivity over other tRNAs not fully dissected\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Purification and mass spectrometry identification of the native 52 kDa SEPSECS protein from human hepatic cells confirmed the identity of the SLA/LP autoantigen as the full-length enzyme.\",\n      \"evidence\": \"Immune affinity chromatography from human liver cell extract, mass spectrometry, monoclonal antibody immunoblot\",\n      \"pmids\": [\"19683415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Post-translational modifications not characterized\", \"Subcellular localization in hepatocytes not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that selenium availability regulates SEPSECS mRNA stability in neurons revealed a post-transcriptional feedback mechanism coupling selenium supply to the selenocysteine biosynthesis pathway.\",\n      \"evidence\": \"In vivo selenium supplementation in chicken brain, mRNA half-life measurement in primary neuronal cultures\",\n      \"pmids\": [\"22536434\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trans-acting factors mediating mRNA stabilization not identified\", \"Not confirmed in mammalian systems\", \"Protein-level regulation not assessed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Establishing that SEPSECS forms oligomeric complexes with SECp43, SEPHS1, and SEPHS2 placed the enzyme within a multi-protein selenocysteine biosynthesis assembly in mammalian cells.\",\n      \"evidence\": \"BRET assay in mammalian cells, co-immunoprecipitation, phage display interaction mapping\",\n      \"pmids\": [\"28414460\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry and architecture of the multi-protein complex not resolved\", \"Functional consequence of complex formation on catalytic activity untested\", \"Whether complex assembly is constitutive or regulated is unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of a homozygous SEPSECS missense mutation causing late-onset cerebellar ataxia expanded the clinical spectrum beyond severe infantile pontocerebellar hypoplasia, confirming SEPSECS as a disease gene for neurodegeneration.\",\n      \"evidence\": \"Whole exome sequencing and clinical phenotyping of affected patient\",\n      \"pmids\": [\"29464431\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No biochemical characterization of the Gly441Arg variant's effect on enzyme activity\", \"Mechanism linking impaired selenocysteine biosynthesis to selective neuronal vulnerability unknown\", \"Single family; genotype–phenotype correlation across mutations not systematically addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SEPSECS activity is regulated in vivo, how its multi-protein complex is assembled and coordinated, and why its loss-of-function preferentially damages the cerebellum remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of the SEPSECS–SECp43–SEPHS complex\", \"Tissue-specific regulation of SEPSECS expression and activity poorly characterized\", \"No cell-biological reconstitution linking SEPSECS deficiency to neuronal selenoprotein loss\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0016853\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 4, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SECp43\", \"SEPHS1\", \"SEPHS2\"],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SEPSECS is the pyridoxal phosphate-dependent enzyme that catalyzes the final step of selenocysteine (Sec) biosynthesis, converting O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) using selenophosphate as the selenium donor [PMID:17142313, PMID:17194211]. The crystal structure of the human enzyme reveals a homotetrameric architecture in which tRNA(Sec) binding—through its distinctive 13-bp acceptor-TΨC arm—induces an active-site conformational change that orients the phosphoseryl moiety for catalysis, thereby enforcing strict substrate discrimination against free phosphoserine [PMID:19608919]. SEPSECS resides in a multiprotein complex with SECp43, SEPHS1, and SEPHS2; SECp43 promotes nucleocytoplasmic shuttling of SEPSECS and is required for full tRNA(Sec) methylation and selenoprotein expression [PMID:16230358, PMID:28414460]. Loss-of-function mutations in SEPSECS abolish selenoprotein synthesis and cause autosomal-recessive progressive cerebellocerebral atrophy (PCCA) and related encephalopathies [PMID:20920667, PMID:26115735].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of SEPSECS as the protein component of the tRNA(Ser)Sec ribonucleoprotein complex resolved the molecular identity of the SLA/LP autoantigen in autoimmune hepatitis and placed the protein within the selenocysteine biosynthesis machinery.\",\n      \"evidence\": \"cDNA expression library immunoscreening; immunoprecipitation of tRNA(Ser)Sec from HeLa cell extracts with eluted antibodies\",\n      \"pmids\": [\"10931155\", \"10801173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic function of the protein not yet demonstrated\", \"Relationship between autoantigenicity and catalytic role unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that SEPSECS forms a complex with SECp43 and tRNA(Sec), and that SECp43 controls SEPSECS nuclear translocation and tRNA(Sec) methylation, established the regulatory context in which SEPSECS operates before its catalytic role was formally proven.\",\n      \"evidence\": \"RNA interference knockdown; co-immunoprecipitation; subcellular fractionation in mammalian cells\",\n      \"pmids\": [\"16230358\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which SECp43 promotes nuclear import of SEPSECS not defined\", \"Relative contributions of cytoplasmic vs. nuclear SEPSECS pools to selenoprotein synthesis unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"In vitro reconstitution and in vivo complementation proved that SEPSECS is the eukaryotic/archaeal Sec synthase, resolving a long-standing gap in the selenocysteine biosynthetic pathway.\",\n      \"evidence\": \"Purified recombinant enzyme assay converting Sep-tRNA(Sec) to Sec-tRNA(Sec); complementation of E. coli SelA deletion\",\n      \"pmids\": [\"17142313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for substrate recognition not yet determined\", \"Selenium donor specificity not fully resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defining the obligatory substrate requirements—O-phosphoseryl-tRNA(Sec) rather than free phosphoserine, and selenophosphate as the selenium donor—established the two-component specificity of the SEPSECS reaction.\",\n      \"evidence\": \"Full reconstitution with purified tRNA, PSTK, SEPSECS, and selenophosphate synthetase; substrate specificity assays\",\n      \"pmids\": [\"17194211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetic parameters and rate-limiting step not characterized\", \"Whether selenophosphate is directly transferred or proceeds via intermediate unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The crystal structure of the SEPSECS–tRNA(Sec) complex revealed the homotetrameric architecture, the PLP-dependent mechanism, and the tRNA-induced conformational change that enforces substrate discrimination, providing an atomic-level explanation for the tRNA-dependent catalysis.\",\n      \"evidence\": \"X-ray crystallography of human SEPSECS with tRNA(Sec), phosphoserine, and thiophosphate; complementary in vivo and in vitro enzyme assays\",\n      \"pmids\": [\"19608919\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the selenophosphate-bound intermediate captured\", \"Dynamics of the conformational switch not resolved at the time-resolved level\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of homozygous loss-of-function SEPSECS mutations as the cause of progressive cerebellocerebral atrophy proved the enzyme is essential for selenoprotein synthesis and normal brain development in humans.\",\n      \"evidence\": \"Homozygosity mapping and sequencing in consanguineous families; clinical phenotyping\",\n      \"pmids\": [\"20920667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific selenoproteins whose loss drives cerebellar neurodegeneration not identified\", \"No animal model recapitulating PCCA phenotype described at this point\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Characterization of hypomorphic SEPSECS mutations extended the genotype-phenotype spectrum, showing that partial enzyme activity leads to reduced but not absent selenoprotein synthesis with elevated oxidative damage, linking disease severity to residual catalytic capacity.\",\n      \"evidence\": \"Whole-exome sequencing; bacterial complementation assay; mass spectrometry and protein oxidation analysis of patient brain tissue\",\n      \"pmids\": [\"26115735\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative relationship between residual SEPSECS activity and selenoprotein output not determined\", \"Contribution of oxidative damage versus specific selenoprotein loss to neuropathology not dissected\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"BRET and co-immunoprecipitation data showed that SEPSECS forms oligomeric assemblies with SEPHS1 and SEPHS2 in cells, extending the interaction network beyond the previously described SECp43 partnership and suggesting a selenocysteine biosynthesis supramolecular complex.\",\n      \"evidence\": \"BRET assay and co-immunoprecipitation in mammalian cells\",\n      \"pmids\": [\"28414460\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of SEPSECS–SEPHS1/2 interaction on catalytic efficiency not measured\", \"Stoichiometry and architecture of the full complex not resolved\", \"Findings from a single laboratory\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the structure of a catalytic intermediate with selenophosphate bound, the identity of the specific selenoproteins whose loss drives cerebellar neurodegeneration, and whether the SEPSECS–SEPHS–SECp43 supramolecular complex channels selenophosphate directly to the active site.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No selenophosphate-bound catalytic intermediate structure\", \"Selenoprotein-specific contributions to PCCA neuropathology unresolved\", \"Substrate channeling within the multiprotein complex not tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2, 4]}\n    ],\n    \"complexes\": [\n      \"Selenocysteine biosynthesis complex (SEPSECS–SECp43–SEPHS1–SEPHS2)\"\n    ],\n    \"partners\": [\n      \"TRNAU1AP\",\n      \"SEPHS1\",\n      \"SEPHS2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}